Much like the surge in demand led to growth in the steel industry in the 19th century, the growing demand for processed food is creating larger opportunities in food protection business. At the heart of food protection business, is food preservation and shelf life extension. Food protection is a complex business encompassing elements of basic chemistry, food chemistry, bio-chemistry and bio-technology.
Camlin Fine Chemicals Ltd was originally incorporated on November 30, 1993 as a private limited company with the name of Camlicon Consultants Pvt Ltd. In April 2006, the main object of the company was altered to enable the company to pursue business in Fine Chemicals.
The company has a strong research and development which is focused on bringing in continual improvements on process and products, backward integration and developing innovative products. The research and development is equipped with comprehensive and updated instrumentation for conducting quality analysis, stability studies. The research and development also is equipped to conduct application studies on stability index of edible oils and Bio-diesel. They launched a new product namely, 'Sucralose' which is a synthetic sweetener with large demand and attractive price.
Camlin Fine Chemicals Ltd is one of the India's leading manufacturers and exporters of Bulk Drugs, Fine Chemicals and Food Grade products. The company manufactures active pharmaceutical ingredients (API's), food antioxidants and sweeteners. They operate in two business divisions, namely Food Ingredients Division and Industrial products Division. The company's products have applications in processed foods, edible oils, paints, polymers, alternative fuels (biodiesel), rubber, health, and pharmaceuticals.
The Company during the financial year under review has registered a growth in sales at 19%. further, the Company was successful in holding on to the market share in major markets and also registered a growth in emerging markets like South America and Asia by extensive customer reach through its sales teams. This growth has been achieved in spite of recessionary pressures in the international market during the year. The growth of the Company is also powered by new and value added products. The Company has increased its market share by 3 highly potential new products from the diphenol down stream as per planned strategy. These products were Tertiary Butyl Catechol (TBC), Guaiacol and Veratrole which has contributed to the growth.
The Company has expanded its sales team in Latin America, India and China to increase customer reach and penetration in the markets. The Company will be shortly establishing an office and distribution hub to improve the service and shorten supply time to customers, in Latin America and China. The Company will also be shortly appointing sales managers in Middle East and Asia to further widen and improve the wider customer base.
In line with the overall growth objective and strengthening of infrastructure base, the Company had invested in Information Technology (IT) viz. SAP Enterprising Resource Planning system for leveraging its business values. Through implementation of SAP the Company has improved its operational efficiencies, inventory minimisation and cost optimization not only for its Indian operations but also in its overseas manufacturing operations at Italy
Gross sales during the year ended 31st March, 2014 were higher at ` 38,289.10 Lacs as against ` 32,276.48 Lacs in the previous year. This is an increase of ` 6,012.62 Lacs in sales over the previous year registering a growth of 18.62%. Profit before tax was ` 2,920.58 Lacs as against 2,252.77 Lacs showing an increase of ` 667.81 Lacs over the previous year registering a growth of 29.64%
The products manufactured by Camlin Fine Science Ltd. are unique and company has good market share. With changing lifestyle and urbanization, market demand for ready-to-eat or packed goods are on the rise. This should augur well for domestic demand growth. Camlin Fine Science Ltd., is indeed a good business to own. For the profits it is expected to post, the stock deserves a better valuation in the short term.
Camlin Fine Chemicals Ltd was originally incorporated on November 30, 1993 as a private limited company with the name of Camlicon Consultants Pvt Ltd. In April 2006, the main object of the company was altered to enable the company to pursue business in Fine Chemicals.
The company has a strong research and development which is focused on bringing in continual improvements on process and products, backward integration and developing innovative products. The research and development is equipped with comprehensive and updated instrumentation for conducting quality analysis, stability studies. The research and development also is equipped to conduct application studies on stability index of edible oils and Bio-diesel. They launched a new product namely, 'Sucralose' which is a synthetic sweetener with large demand and attractive price.
Camlin Fine Chemicals Ltd is one of the India's leading manufacturers and exporters of Bulk Drugs, Fine Chemicals and Food Grade products. The company manufactures active pharmaceutical ingredients (API's), food antioxidants and sweeteners. They operate in two business divisions, namely Food Ingredients Division and Industrial products Division. The company's products have applications in processed foods, edible oils, paints, polymers, alternative fuels (biodiesel), rubber, health, and pharmaceuticals.
The Company during the financial year under review has registered a growth in sales at 19%. further, the Company was successful in holding on to the market share in major markets and also registered a growth in emerging markets like South America and Asia by extensive customer reach through its sales teams. This growth has been achieved in spite of recessionary pressures in the international market during the year. The growth of the Company is also powered by new and value added products. The Company has increased its market share by 3 highly potential new products from the diphenol down stream as per planned strategy. These products were Tertiary Butyl Catechol (TBC), Guaiacol and Veratrole which has contributed to the growth.
The Company has expanded its sales team in Latin America, India and China to increase customer reach and penetration in the markets. The Company will be shortly establishing an office and distribution hub to improve the service and shorten supply time to customers, in Latin America and China. The Company will also be shortly appointing sales managers in Middle East and Asia to further widen and improve the wider customer base.
In line with the overall growth objective and strengthening of infrastructure base, the Company had invested in Information Technology (IT) viz. SAP Enterprising Resource Planning system for leveraging its business values. Through implementation of SAP the Company has improved its operational efficiencies, inventory minimisation and cost optimization not only for its Indian operations but also in its overseas manufacturing operations at Italy
Gross sales during the year ended 31st March, 2014 were higher at ` 38,289.10 Lacs as against ` 32,276.48 Lacs in the previous year. This is an increase of ` 6,012.62 Lacs in sales over the previous year registering a growth of 18.62%. Profit before tax was ` 2,920.58 Lacs as against 2,252.77 Lacs showing an increase of ` 667.81 Lacs over the previous year registering a growth of 29.64%
The products manufactured by Camlin Fine Science Ltd. are unique and company has good market share. With changing lifestyle and urbanization, market demand for ready-to-eat or packed goods are on the rise. This should augur well for domestic demand growth. Camlin Fine Science Ltd., is indeed a good business to own. For the profits it is expected to post, the stock deserves a better valuation in the short term.
Posts
1 comments:
Good information!Thanks for sharing
Camlin Fine Sciences Limited
Post a Comment